Follow US:
In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and deadly human malaria parasite. For decades, the parasite’s resistance to all antimalarial drugs has posed a big challenge for researchers working to stop the spread of the disease. A team led...
Identification of RNA-binding proteins using R-DeeP reveals new drug targets
UC Riverside-led study zeroes in on special RNA molecules in the human malaria parasite
UC Riverside and Yale University team sequences and mines genome of the pathogen Babesia duncani
UC Riverside-led research could lead to novel antimalarial therapeutic strategies
UC Riverside experts share their thoughts on the new COVID-19 variant
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
C OVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside...
The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...
Study co-led by UC Riverside scientist could help develop strategies to combat the disease
UC Riverside-led research could help develop novel therapeutic strategies to combat malaria
UC Riverside’s Karine Le Roch is principal investigator on two NIH grants
A team of researchers led by a University of California, Riverside, scientist has found that various stages of the development of human malaria parasites, including stages involved in malaria transmission, are linked to epigenetic features and how chromatin — the complex of DNA and proteins within the nucleus — is...
